StockGuru Leader Board: Corcept Therapeutics (NASDAQ: CORT) Closed Up 46.86% on Tuesday

Corcept Therapeutics (NASDAQ: CORT) is on The StockGuru Leader Board today.  The stock closed up 46.86% on Tuesday.

Volume was 11,894,078 shares traded.

Join in on the Discussion about CORT

About the Company:

Corcept Therapeutics Incorporated, a development stage pharmaceutical company, engages in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. The company focuses on the development of drugs for disorders that are associated with steroid hormone called cortisol. Corcept Therapeutics Incorporated has completed its Phase III study of CORLUX for the treatment of Cushing’s Syndrome, as well as has an ongoing Phase III study of CORLUX for the treatment of the psychotic features of psychotic depression; and a Phase II program for CORT 108297 and an IND-enabling program for CORT 113083. It has a patent license from Stanford University for the use of GR-II antagonists, as well as agreements with ICON Clinical Research, LP; and MedAvante, Inc. The company was founded in 1998 and is based in Menlo Park, California.

About the StockGuru Leader Board:

We watch for stocks moving up and creating a positive momentum in the market.  We are not compensated for coverage.

Feel free to suggest a stock for coverage if you see it breaking out.  Contact:
IR Affiliates –
StoneBridge Web & SEO –

All content on is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070